Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
International audienceAbstractBackgroundMolecular understanding of muscle-invasive (MIBC) and non–mu...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disrup-tions and al...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Curs 2016-2017To move toward a molecular taxonomy, we investigated three genome-wide platform data,...
Objective In order to improve the accuracy in distinguishing subtypes of bladder cancer and to explo...
Objectives: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladde...
OBJECTIVES: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladde...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
Bladder cancer remains one of the most common forms of cancer and yet there are limited small molecu...
Bladder cancer is a biologically and clinically heterogeneous disease. Traditional classification sy...
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with distinct mol...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
International audienceAbstractBackgroundMolecular understanding of muscle-invasive (MIBC) and non–mu...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disrup-tions and al...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Curs 2016-2017To move toward a molecular taxonomy, we investigated three genome-wide platform data,...
Objective In order to improve the accuracy in distinguishing subtypes of bladder cancer and to explo...
Objectives: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladde...
OBJECTIVES: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladde...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
Bladder cancer remains one of the most common forms of cancer and yet there are limited small molecu...
Bladder cancer is a biologically and clinically heterogeneous disease. Traditional classification sy...
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with distinct mol...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
International audienceAbstractBackgroundMolecular understanding of muscle-invasive (MIBC) and non–mu...